bioRxivImmunology
The SARS-CoV-2 Y453F mink variant displays a striking increase in ACE-2 affinity but does not challenge antibody neutralization
R. Bayarri-Olmos, A. Rosbjerg, L. B. Johnsen, C. Helgstrand, T. Bak-Thomsen, P. Garred, M.-O. Skjoedt
Abstract
SARS-CoV-2 transmission from humans to animals has been reported for many domesticated species, including cats, dogs and minks. Identification of novel spike gene mutations appearing in minks has raised major concerns about potential immune evasion and challenges for the global vaccine strategy. The genetic variant, known as "cluster-five", arose among farmed minks in Denmark and resulted in a complete shutdown of the worlds largest mink production. However, the functional properties of this new variant are not established. Here we present functional data on the Y453F cluster-five receptor-binding domain (RBD) and show that it does not decrease established humoral immunity or affect the neutralizing response in a vaccine model based on wild-type RBD or spike. However, it binds the human ACE-2 receptor with a four-fold higher affinity suggesting an enhanced transmission capacity and a possible challenge for viral control.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
- SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Markus Hoffmann, Lu Zhang, … Stefan Pöhlmann·Cell ReportsPeer-reviewed·Apr 1, 2021
- Effect of RBD mutation (Y453F) in spike glycoprotein of SARS-CoV-2 on neutralizing antibody affinity
T. Hayashi, N. Yaegashi, I. Konishi·bioRxiv·Nov 27, 2020
- The basis of a more contagious 501Y.V1 variant of SARS-COV-2
G. Zhang, H. Liu, … P. Marrack·bioRxiv·Feb 2, 2021
- SARS-CoV-2 variants resist antibody neutralization and broaden host ACE2 usage
- Relative Mutant N501Y SARS-CoV-2 Spike Protein RBD Inhibition of Anti-Spike Protein IgG and ACE-2 Binding to Spike Protein Species
M. E. Klegerman, J. D. Cirillo, D. D. McPherson·bioRxiv·Apr 26, 2021